EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/16/2026
Back to search
Official data from USPTO
ZEGFROVY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/18/2026
Trademark type
Combined
Nice classes
5
Filing date
06/07/2022
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
06/18/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/04/2023
First use in commerce
12/04/2023
Drawing code
3
Owner type
03
Owner location
Wuxi City, Jiangsu, CN
Examiner
DELGIZZI, RONALD ERNEST
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the literal element "ZEGFROVY" to the right of a design consisting of two pairs of differing fanciful geometric shapes intended to depict a gene mutation process.
Holders and representatives
Holders
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Representatives
He Li
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibioticsunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparationpreparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouthfor pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposesfor anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnessesanti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnessesanti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine casescomprised of pharmaceuticals for treatment of human illnessesanti-tumor treatment; first-aid boxesfilled; fungicides; gelatine for medical purposesgelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineralbath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparationsa blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; pharmaceutical preparationselixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposesanti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugspharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnessesanti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use
Publications
History of USPTO decisions and trademark events.
35 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/16/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/16/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/28/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2024
ALIE
ASSIGNED TO LIE
10/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/15/2024
GNRT
NON-FINAL ACTION E-MAILED
03/15/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/15/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/29/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/29/2024
IUAF
USE AMENDMENT FILED
02/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/25/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/22/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2023
GNRT
NON-FINAL ACTION E-MAILED
03/22/2023
CNRT
NON-FINAL ACTION WRITTEN
03/22/2023
DOCK
ASSIGNED TO EXAMINER
03/22/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/16/2022
NWAP
NEW APPLICATION ENTERED
06/10/2022
Continuous trademark protection
Get notified about every new filing that threatens ZEGFROVY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.